Your browser doesn't support javascript.
loading
Re-evaluation of soluble APP-α and APP-ß in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders.
Araki, Wataru; Hattori, Kotaro; Kanemaru, Kazutomi; Yokoi, Yuma; Omachi, Yoshie; Takano, Harumasa; Sakata, Masuhiro; Yoshida, Sumiko; Tsukamoto, Tadashi; Murata, Miho; Saito, Yuko; Kunugi, Hiroshi; Goto, Yu-Ichi; Nagaoka, Utako; Nagao, Masahiro; Komori, Takashi; Arima, Kunimasa; Ishii, Kenji; Murayama, Shigeo; Matsuda, Hiroshi; Tachimori, Hisateru; Araki, Yumiko M; Mizusawa, Hidehiro.
Afiliação
  • Araki W; Department of Demyelinating Disease and Aging, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8502 Japan.
  • Hattori K; Medical Genome Center, NCNP, Tokyo, Japan.
  • Kanemaru K; Department of Mental Disorder Research, National Institute of Neuroscience, NCNP, Tokyo, Japan.
  • Yokoi Y; Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.
  • Omachi Y; National Center Hospital, NCNP, Tokyo, Japan.
  • Takano H; National Center Hospital, NCNP, Tokyo, Japan.
  • Sakata M; National Center Hospital, NCNP, Tokyo, Japan.
  • Yoshida S; National Center Hospital, NCNP, Tokyo, Japan.
  • Tsukamoto T; National Center Hospital, NCNP, Tokyo, Japan.
  • Murata M; National Center Hospital, NCNP, Tokyo, Japan.
  • Saito Y; National Center Hospital, NCNP, Tokyo, Japan.
  • Kunugi H; National Center Hospital, NCNP, Tokyo, Japan.
  • Goto YI; Department of Mental Disorder Research, National Institute of Neuroscience, NCNP, Tokyo, Japan.
  • Nagaoka U; Medical Genome Center, NCNP, Tokyo, Japan.
  • Nagao M; Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
  • Komori T; Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
  • Arima K; Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
  • Ishii K; Komoro Kogen Hospital, Komoro, Japan.
  • Murayama S; Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.
  • Matsuda H; Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.
  • Tachimori H; Integrative Brain Imaging Center, NCNP, Tokyo, Japan.
  • Araki YM; Department of Mental Health Policy and Evaluation, National Institute of Mental Health, NCNP, Tokyo, Japan.
  • Mizusawa H; Department of Demyelinating Disease and Aging, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8502 Japan.
Biomark Res ; 5: 28, 2017.
Article em En | MEDLINE | ID: mdl-29018524

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Biomark Res Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Biomark Res Ano de publicação: 2017 Tipo de documento: Article